Lv4
460 积分 2025-11-23 加入
Early real-world experience monitoring circulating tumor DNA in resected early-stage non-small cell lung cancer
2个月前
已完结
Efficacy and safety of aumolertinib/icotinib combination therapy for naive EGFR -mutant non–small-cell lung cancer patients with brain metastases: A phase I/II study
4个月前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
4个月前
已完结
Circulating tumor DNA in early-stage NSCLC: prognostic value and challenges
7个月前
已完结
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy
7个月前
已完结
Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)
8个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
9个月前
已完结
皖公网安备34019202002308
